Neuroprotective Effects of Tinospora Cordifolia Against Rotenone-Induced Parkinsonism: Behavioural, Biochemical and Neurochemical Evidence

Introduction: Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with the loss of dopaminergic neurons in the substantia nigra, oxidative stress, mitochondrial dysfunction, and neuroinflammation. The rotenone-induced model reproduces key motor and neurochemical features of Parkinsonism and provides a useful experimental approach for investigating potential neuroprotective agents. Objectives: To evaluate the neuroprotective potential of a standardised hydroalcoholic extract of Tinospora cordifolia against rotenone-induced Parkinsonism in Wistar rats. Methods: Adult male Wistar rats were divided into four groups (n = 6 per group): normal control, rotenone control, standard drug-treated, and T. cordifolia-treated groups. Rotenone (2 mg/kg, subcutaneously) was administered daily for 35 days. The standard treatment consisted of levodopa (100 mg/kg) and carbidopa (10 mg/kg), while the test group received T. cordifolia extract (400 mg/kg, orally). Behavioural assessments included the rotarod test, pole test, open-field test, catalepsy test, and grip-strength test. Biochemical and neurochemical parameters included superoxide dismutase (SOD), catalase, reduced glutathione (GSH), malondialdehyde (MDA), nitrite, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). Histopathological examination and tyrosine hydroxylase (TH) immunohistochemistry were also performed. Results: Compared with the rotenone control group, T. cordifolia-treated rats showed improvements in motor performance, including increased rotarod latency, locomotor activity, and grip strength, along with reductions in pole-test descent time and catalepsy duration. The extract-treated group also exhibited higher antioxidant enzyme activity and GSH levels, increased dopamine and its metabolite concentrations, and lower MDA, nitrite, and pro-inflammatory cytokine levels. Histopathological observations indicated comparatively better preservation of neuronal morphology, while TH-positive neuron counts were higher in the extract-treated group than in the rotenone control group. Conclusions: The hydroalcoholic extract of Tinospora cordifolia at 400 mg/kg was associated with improvements in behavioural, biochemical, neurochemical, inflammatory, and histological parameters in rotenone-induced Parkinsonism in rats. These findings suggest potential neuroprotective activity involving antioxidant and anti-inflammatory effects and partial preservation of dopaminergic neuronal characteristics. Further studies are required to establish the underlying mechanisms, dose-dependent effects, and reproducibility of these findings.

Authors

Publication Details

Journal
Journal of chemical health risks
Published
2026-11-02
Primary Topic
Parkinson's Disease Mechanisms and Treatments
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Neuroprotective Effects of Tinospora Cordifolia Against Rotenone-Induced Parkinsonism: Behavioural, Biochemical and Neurochemical Evidence

Pooja Arora Twinkle Kumari
Journal of chemical health risks
Parkinson's Disease Mechanisms and Treatments
article

Neuroprotective Effects of Tinospora Cordifolia Against Rotenone-Induced Parkinsonism: Behavioural, Biochemical and Neurochemical Evidence

Pooja Arora Twinkle Kumari
article en

Abstract

Introduction: Parkinson’s disease (PD) is a progressive neurodegenerative disorder associated with the loss of dopaminergic neurons in the substantia nigra, oxidative stress, mitochondrial dysfunction, and neuroinflammation. The rotenone-induced model reproduces key motor and neurochemical features of Parkinsonism and provides a useful experimental approach for investigating potential neuroprotective agents. Objectives: To evaluate the neuroprotective potential of a standardised hydroalcoholic extract of Tinospora cordifolia against rotenone-induced Parkinsonism in Wistar rats. Methods: Adult male Wistar rats were divided into four groups (n = 6 per group): normal control, rotenone control, standard drug-treated, and T. cordifolia-treated groups. Rotenone (2 mg/kg, subcutaneously) was administered daily for 35 days. The standard treatment consisted of levodopa (100 mg/kg) and carbidopa (10 mg/kg), while the test group received T. cordifolia extract (400 mg/kg, orally). Behavioural assessments included the rotarod test, pole test, open-field test, catalepsy test, and grip-strength test. Biochemical and neurochemical parameters included superoxide dismutase (SOD), catalase, reduced glutathione (GSH), malondialdehyde (MDA), nitrite, dopamine, 3,4-dihydroxyphenylacetic acid (DOPAC), homovanillic acid (HVA), and pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6). Histopathological examination and tyrosine hydroxylase (TH) immunohistochemistry were also performed. Results: Compared with the rotenone control group, T. cordifolia-treated rats showed improvements in motor performance, including increased rotarod latency, locomotor activity, and grip strength, along with reductions in pole-test descent time and catalepsy duration. The extract-treated group also exhibited higher antioxidant enzyme activity and GSH levels, increased dopamine and its metabolite concentrations, and lower MDA, nitrite, and pro-inflammatory cytokine levels. Histopathological observations indicated comparatively better preservation of neuronal morphology, while TH-positive neuron counts were higher in the extract-treated group than in the rotenone control group. Conclusions: The hydroalcoholic extract of Tinospora cordifolia at 400 mg/kg was associated with improvements in behavioural, biochemical, neurochemical, inflammatory, and histological parameters in rotenone-induced Parkinsonism in rats. These findings suggest potential neuroprotective activity involving antioxidant and anti-inflammatory effects and partial preservation of dopaminergic neuronal characteristics. Further studies are required to establish the underlying mechanisms, dose-dependent effects, and reproducibility of these findings.

Journal of chemical health risks
Openalex Percentile: Top 15%
Parkinson's Disease Mechanisms and Treatments
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon